NOVOZYMES A/S: Financial statements 2024
CVR: 10007127
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
NOVOZYMES A/S (CVR 10007127) has filed annual accounts for 2024. In 2024, the company reported revenue of EUR 3,833,500,000 and a net result of EUR 305,800,000 compared with DKK 3,039,000,000 the year before. That is a decrease of 78.6% compared with the year before. The profit margin was 8%. Equity in the 2024 report amounted to EUR 11,176,000,000. The solvency ratio was 73.5%. The company had 10,208 employees in the financial year.
- Revenue
- EUR 3,833,500,000
- Gross Profit
- EUR 1,809,500,000
- Profit/Loss
- EUR 305,800,000
- Equity
- EUR 11,176,000,000
- Total Assets
- EUR 15,195,600,000
- Employees
- 10,208
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 3.8B EUR | 1.8B EUR | 305.8M EUR | 11.2B EUR | 10208 |
| 2023 | 17.9B | 9.7B | 3B | 14.4B | 6805 |
| 2022 | 17.6B | 9.6B | 3.7B | 14.2B | 6690 |
| 2021 | 15B | 8.6B | 3.1B | 12.2B | 6240 |
| 2020 | 14B | 7.9B | 2.8B | 11.2B | 6099 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of December 31, 2024, Sharon James has left the board of directors of NOVOZYMES A/S.
As of November 1, 2024, Lena Bech Holskov has joined the board of directors of NOVOZYMES A/S.
As of November 1, 2024, Anne Elme Breum has left the board of directors of NOVOZYMES A/S.
As of October 31, 2024, Lena Bech Holskov has left the board of directors of NOVOZYMES A/S.
NOVOZYMES A/S has published its interim report for the period January 1, 2024 to June 30, 2024.
As of June 20, 2024, Novo Holdings A/S is registered as an owner of NOVOZYMES A/S with an ownership share of 25%.
NOVOZYMES A/S has published its annual report for 2023. Revenue came to DKK 17,899,000,000, and the net result was DKK 3,039,000,000.
As of April 30, 2024, EY Godkendt Revisionspartnerselskab has been appointed auditor of NOVOZYMES A/S.
As of April 30, 2024, EY Godkendt Revisionspartnerselskab has been appointed auditor of NOVOZYMES A/S.
As of April 30, 2024, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of NOVOZYMES A/S.
About NOVOZYMES A/S
NOVOZYMES A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 2000. The company is registered under the industry Fremstilling af andre organiske basiskemikalier. The management consists of Ester Baiget Arnau and Rainer Chapour Lehmann. The board consists of Cornelis de Jong (chair), Heine Dalsgaard, Frederikke Rose Spenner and Kasim Kutay. The company is owned by Novo Holdings A/S and BlackRock, Inc.. The company has 3,508 employees (2026). In 2025, the company reported revenue of EUR 4,157,600,000 and a net result of EUR 583,600,000 compared with EUR 305,800,000 the year before. Equity in the 2025 report amounted to EUR 10,855,200,000.